# A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain

> **NCT02381132** · PHASE3 · TERMINATED · sponsor: **Neil Singla** · enrollment: 99 (actual)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** Norco 7.5mg/325
- **DRUG:** MNK155

## Key facts

- **NCT ID:** NCT02381132
- **Lead sponsor:** Neil Singla
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2016-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381132, "A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02381132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*